![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, May 30, 2021 9:33:38 PM
Covered entities rely upon the 340B program to effectively serve the neediest patients in their community.
• Loss of 340B pricing at contract pharmacies resulted in lack of patient access to lifesaving medications and reduced covered entity revenue potential.
$ $ • Other than establishing the June 1 deadline for drug companies’ compliance plans, HRSA has not yet released more information on how or when affected covered entities might receive the millions of dollars lost through denied 340B drug pricing program discounts.
$ $ • To encourage 340B Program Integrity, a policy for the covered entity to file a notice to HRSA of overpayment for covered entities contracted pharmacy arrangements should be enacted. Report manufacturer overcharges or a lack of 340B pricing, to HRSA, using the 340B Ceiling Price Unavailable/Incorrect 340B Ceiling Price Notification template.
• To access financial damages, take the labeler code within the NDC (first 5 digits of the 11-digit NDC
number identifies the manufacturer) for those 6 manufacturers and tally up the number of
prescription transactions that went to a contract pharmacy and were prevented from dispensing under the 340B discount program.
• To develop analytic proof of financial damages, work with the drug wholesale distributor to calculate the financial loss for each transaction (WAC Price-340B Price= amount owed to covered entity) and total the sum for the time period of 10/1/2020 to present.
• Be patient, as clarity for the next steps will take some time. These six drug companies have fought every effort to gain adherence with the law since the start of this issue. Vizient will continue to
monitor and advise.
Recent RXMD News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 03:51:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/06/2024 08:54:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 07:54:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 04:38:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 04:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:40:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:34:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:20:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:04:51 PM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM